Delivery Order SPE2DB22D2211-SPE2DB24FNFX4

Award Date 4/18/24
Potential Completion Date 5/9/24
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 25% intravenous albumin solution. The contract has a firm fixed price of $14,022.24 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This award is associated with a larger indefinite delivery contract (IDC) with a...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of albumin (human) 5% IV solution in 250 ml containers. The award has a ceiling value of $1,456.80 and an ultimate completion date of August 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,109.70 for the supply of Albumin (Human) 5% IV Solution 250ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of July 18, 2024 and was awarded on June 26, 2024 as a Firm Fixed Price contract. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide 250ml 5% albumin (human) IV solution. The $1,214.00 award has a completion date of March 1, 2024 and does not utilize any set-aside designations. This delivery order is issued under Amerisourcebergen Drug Corp's single award indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a...
This federal contract award, valued at $2,260.44, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Albumin (Human) 5% IV Solution 250ML, with a completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Albumin (Human) 25% IV Solution 50ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,206.24, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Albumin (Human) 25% IV Solution 100mL to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $1,040.10 and is structured as a delivery order. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a ceiling value of $2,412.96 and an ultimate completion date of August 21, 2024. This award is a delivery order issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Albumin (Human) 5% IV Solution 250 ML, a critical medical commodity. The contract has a ceiling value of $1,255.80 and a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 50 ml vials of 25% albumin (human) intravenous solution, with a ceiling value of $1,934.64 and a completion date of January 8, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a larger $999,999,999 Indefinite...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNFX4
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 100 ml intravenous (IV) albumin (human) solution at a ceiling value of $2,010.80. The contract has an ultimate completion date of May 9, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen's extensive supply chain and expertise in pharmaceutical distribution enable it to competitively fulfill government contracts for critical medical products across various federal agencies.

Generated 7/18/24, 9:56 AM